Literature DB >> 23318931

Early mitochondrial dysfunction leads to altered redox chemistry underlying pathogenesis of TPI deficiency.

Stacy L Hrizo1, Isaac J Fisher, Daniel R Long, Joshua A Hutton, Zhaohui Liu, Michael J Palladino.   

Abstract

Triose phosphate isomerase (TPI) is responsible for the interconversion of dihydroxyacetone phosphate to glyceraldehyde-3-phosphate in glycolysis. Point mutations in this gene are associated with a glycolytic enzymopathy called TPI deficiency. This study utilizes a Drosophila melanogaster model of TPI deficiency; TPI(sugarkill) is a mutant allele with a missense mutation (M80T) that causes phenotypes similar to human TPI deficiency. In this study, the redox status of TPI(sugarkill) flies was examined and manipulated to provide insight into the pathogenesis of this disease. Our data show that TPI(sugarkill) animals exhibit higher levels of the oxidized forms of NAD(+), NADP(+) and glutathione in an age-dependent manner. Additionally, we demonstrate that mitochondrial redox state is significantly more oxidized in TPI(sugarkill) animals. We hypothesized that TPI(sugarkill) animals may be more sensitive to oxidative stress and that this may underlie the progressive nature of disease pathogenesis. The effect of oxidizing and reducing stressors on behavioral phenotypes of the TPI(sugarkill) animals was tested. As predicted, oxidative stress worsened these phenotypes. Importantly, we discovered that reducing stress improved the behavioral and longevity phenotypes of the mutant organism without having an effect on TPI(sugarkill) protein levels. Overall, these data suggest that reduced activity of TPI leads to an oxidized redox state in these mutants and that the alleviation of this stress using reducing compounds can improve the mutant phenotypes.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23318931      PMCID: PMC3628936          DOI: 10.1016/j.nbd.2012.12.020

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  46 in total

1.  HEREDITARY HEMOLYTIC ANEMIA WITH TRIOSEPHOSPHATE ISOMERASE DEFICIENCY.

Authors:  A S SCHNEIDER; W N VALENTINE; M HATTORI; H L HEINS
Journal:  N Engl J Med       Date:  1965-02-04       Impact factor: 91.245

2.  Cells have distinct mechanisms to maintain protection against different reactive oxygen species: oxidative-stress-response genes.

Authors:  Geoffrey W Thorpe; Chii S Fong; Nazif Alic; Vincent J Higgins; Ian W Dawes
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-15       Impact factor: 11.205

3.  wasted away, a Drosophila mutation in triosephosphate isomerase, causes paralysis, neurodegeneration, and early death.

Authors:  Joshua P Gnerer; Robert A Kreber; Barry Ganetzky
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-28       Impact factor: 11.205

Review 4.  Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease: many pathways to neurodegeneration.

Authors:  D Allan Butterfield; Sarita S Hardas; Miranda L Bader Lange
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

5.  Triosephosphate isomerase deficiency: haemolytic anaemia, myopathy with altered mitochondria and mental retardation due to a new variant with accelerated enzyme catabolism and diminished specific activity.

Authors:  S W Eber; A Pekrun; A Bardosi; M Gahr; W K Krietsch; J Krüger; R Matthei; W Schröter
Journal:  Eur J Pediatr       Date:  1991-09       Impact factor: 3.183

6.  Modification of glycolysis affects cell sensitivity to apoptosis induced by oxidative stress and mediated by mitochondria.

Authors:  Dae-won Jeong; Tae-Soo Kim; Il Taeg Cho; Ick Young Kim
Journal:  Biochem Biophys Res Commun       Date:  2004-01-23       Impact factor: 3.575

Review 7.  Triosephosphate isomerase deficiency: facts and doubts.

Authors:  Ferene Orosz; Judit Oláh; Judit Ovádi
Journal:  IUBMB Life       Date:  2006-12       Impact factor: 3.885

8.  Pyruvate kinase triggers a metabolic feedback loop that controls redox metabolism in respiring cells.

Authors:  Nana-Maria Grüning; Mark Rinnerthaler; Katharina Bluemlein; Michael Mülleder; Mirjam M C Wamelink; Hans Lehrach; Cornelis Jakobs; Michael Breitenbach; Markus Ralser
Journal:  Cell Metab       Date:  2011-09-07       Impact factor: 27.287

9.  Triose phosphate isomerase deficiency is caused by altered dimerization--not catalytic inactivity--of the mutant enzymes.

Authors:  Markus Ralser; Gino Heeren; Michael Breitenbach; Hans Lehrach; Sylvia Krobitsch
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240

10.  Hydrogen peroxide stimulates activity and alters behavior in Drosophila melanogaster.

Authors:  Dhruv Grover; Daniel Ford; Christopher Brown; Nicholas Hoe; Aysen Erdem; Simon Tavaré; John Tower
Journal:  PLoS One       Date:  2009-10-28       Impact factor: 3.240

View more
  8 in total

1.  Triosephosphate isomerase I170V alters catalytic site, enhances stability and induces pathology in a Drosophila model of TPI deficiency.

Authors:  Bartholomew P Roland; Christopher G Amrich; Charles J Kammerer; Kimberly A Stuchul; Samantha B Larsen; Sascha Rode; Anoshé A Aslam; Annie Heroux; Ronald Wetzel; Andrew P VanDemark; Michael J Palladino
Journal:  Biochim Biophys Acta       Date:  2014-10-16

2.  Solution Chemistry of Dihydroxyacetone and Synthesis of Monomeric Dihydroxyacetone.

Authors:  Luxene Belfleur; Manoj Sonavane; Arlet Hernandez; Natalie R Gassman; Marie E Migaud
Journal:  Chem Res Toxicol       Date:  2022-03-24       Impact factor: 3.973

3.  Structural analysis on mutation residues and interfacial water molecules for human TIM disease understanding.

Authors:  Zhenhua Li; Ying He; Qian Liu; Liang Zhao; Limsoon Wong; Chee Keong Kwoh; Hung Nguyen; Jinyan Li
Journal:  BMC Bioinformatics       Date:  2013-10-22       Impact factor: 3.169

4.  Identification of protein quality control regulators using a Drosophila model of TPI deficiency.

Authors:  Stacy L Hrizo; Samantha L Eicher; Tracey D Myers; Ian McGrath; Andrew P K Wodrich; Hemanth Venkatesh; Daniel Manjooran; Sabrina Swoger; Kim Gagnon; Matthew Bruskin; Maria V Lebedev; Sherry Zheng; Ana Vitantonio; Sungyoun Kim; Zachary J Lamb; Andreas Vogt; Maura R Z Ruzhnikov; Michael J Palladino
Journal:  Neurobiol Dis       Date:  2021-02-15       Impact factor: 5.996

5.  Itavastatin and resveratrol increase triosephosphate isomerase protein in a newly identified variant of TPI deficiency.

Authors:  Andrew P VanDemark; Stacy L Hrizo; Samantha L Eicher; Jules Kowalski; Tracey D Myers; Megan R Pfeifer; Kacie N Riley; Dwight D Koeberl; Michael J Palladino
Journal:  Dis Model Mech       Date:  2022-05-17       Impact factor: 5.732

Review 6.  The return of metabolism: biochemistry and physiology of the pentose phosphate pathway.

Authors:  Anna Stincone; Alessandro Prigione; Thorsten Cramer; Mirjam M C Wamelink; Kate Campbell; Eric Cheung; Viridiana Olin-Sandoval; Nana-Maria Grüning; Antje Krüger; Mohammad Tauqeer Alam; Markus A Keller; Michael Breitenbach; Kevin M Brindle; Joshua D Rabinowitz; Markus Ralser
Journal:  Biol Rev Camb Philos Soc       Date:  2014-09-22

7.  A High-Content Screening Assay for Small Molecules That Stabilize Mutant Triose Phosphate Isomerase (TPI) as Treatments for TPI Deficiency.

Authors:  Andreas Vogt; Samantha L Eicher; Tracey D Myers; Stacy L Hrizo; Laura L Vollmer; E Michael Meyer; Michael J Palladino
Journal:  SLAS Discov       Date:  2021-06-24       Impact factor: 3.341

8.  Structural and Genetic Studies Demonstrate Neurologic Dysfunction in Triosephosphate Isomerase Deficiency Is Associated with Impaired Synaptic Vesicle Dynamics.

Authors:  Bartholomew P Roland; Alison M Zeccola; Samantha B Larsen; Christopher G Amrich; Aaron D Talsma; Kimberly A Stuchul; Annie Heroux; Edwin S Levitan; Andrew P VanDemark; Michael J Palladino
Journal:  PLoS Genet       Date:  2016-03-31       Impact factor: 5.917

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.